Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02RVN
|
||||
Former ID |
DIB010636
|
||||
Drug Name |
Selurampanel
|
||||
Synonyms |
BGG-492; BGG-492A; AMPA antagonist (oral, epilepsy), Novartis
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Epilepsy [ICD10:G40] | Phase 2 | [523372] | ||
Company |
Novartis pharmaceuticals
|
||||
Structure |
Download2D MOL |
||||
Formula |
C16H19N5O4S
|
||||
Canonical SMILES |
CS(=O)(=O)Nn1c(=O)[nH]c2c(c1=O)cc(c(c2)C(C)C)c1n(ncc1)C
|
||||
CAS Number |
CAS 912574-69-7
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Glutamate receptor AMPA subtype | Target Info | Antagonist | [532519] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.